ARTICLE
8 January 2021

Health Law Diagnosed — Bioethical Considerations In A Pandemic

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Mounting anxiety over how to control the spread of infectious disease outbreaks encourages public and political discourse of bioethics.
United States Food, Drugs, Healthcare, Life Sciences

Mounting anxiety over how to control the spread of infectious disease outbreaks encourages public and political discourse of bioethics. In the third episode of Mintz's Health Law Diagnosed, Mintz's Bridgette Keller talks about the legal, public health, and bioethics concerns inherent in a global pandemic, including allocating scarce medical resources such as COVID-19 vaccine, and how the greatest challenge to vaccine distribution may be the public's hesitancy.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More